LAV ImmuneOnco Hong Kong Limited - Net Worth and Insider Trading
LAV ImmuneOnco Hong Kong Limited Net Worth
The estimated net worth of LAV ImmuneOnco Hong Kong Limited is at least $220 Million dollars as of 2024-06-22. LAV ImmuneOnco Hong Kong Limited is the 2101 Beneficial owner of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 15,178,770 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $220 Million. Details can be seen in LAV ImmuneOnco Hong Kong Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that LAV ImmuneOnco Hong Kong Limited has not made any transactions after 2023-09-05 and currently still holds the listed stock(s).
Transaction Summary of LAV ImmuneOnco Hong Kong Limited
LAV ImmuneOnco Hong Kong Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, LAV ImmuneOnco Hong Kong Limited owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .
Insider Ownership Summary of LAV ImmuneOnco Hong Kong Limited
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 2101 Beneficial owner |
LAV ImmuneOnco Hong Kong Limited Latest Holdings Summary
LAV ImmuneOnco Hong Kong Limited currently owns a total of 1 stock. LAV ImmuneOnco Hong Kong Limited owns 15,178,770 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of September 5, 2023, with a value of $220 Million.
Latest Holdings of LAV ImmuneOnco Hong Kong Limited
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 15,178,770 | 14.48 | 219,788,590 |
Holding Weightings of LAV ImmuneOnco Hong Kong Limited
LAV ImmuneOnco Hong Kong Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, LAV ImmuneOnco Hong Kong Limited has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 15,178,770 shares on September 5, 2023, which brought LAV ImmuneOnco Hong Kong Limited around $0.
Insider Trading History of LAV ImmuneOnco Hong Kong Limited
- 1
LAV ImmuneOnco Hong Kong Limited Trading Performance
LAV ImmuneOnco Hong Kong Limited Ownership Network
Ownership Network List of LAV ImmuneOnco Hong Kong Limited
Ownership Network Relation of LAV ImmuneOnco Hong Kong Limited
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
LAV ImmuneOnco Hong Kong Limited Owned Company Details
What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?
Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?
LAV ImmuneOnco Hong Kong Limited is the 2101 Beneficial owner of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include Ho Yao , CHENG YIQUAN , and 2102 Investment manager LAV Asset Management (Hong Kong) Limited .
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary
Over the past 18 months, LAV ImmuneOnco Hong Kong Limited made 1 insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) with a net sale of 0. Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net sale of 0 shares made by Greater Bay Area Homeland Investments Limited , a net sale of 0 shares made by Shi Yi , and a net sale of 0 shares made by Tian Wenzhi .
In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions
LAV ImmuneOnco Hong Kong Limited Mailing Address
Above is the net worth, insider trading, and ownership report for LAV ImmuneOnco Hong Kong Limited. Currently GuruFocus does not have mailing address information for LAV ImmuneOnco Hong Kong Limited.